Cognitive functioning in progressive myoclonus epilepsy type 1 (Unverricht-Lundborg Disease, EPM1)

Abstract

The aim of this neuropsychological study of a large cohort of patients with progressive myoclonus epilepsy type 1 (Unverricht-Lundborg disease, EPM1) was to characterize the cognitive function of EPM1 patients and to explore the association between the disability caused by the disease and cognitive performance. Method: Sixty-eight genetically verified EPM1 patients homozygous for the expansion mutation in the CSTB gene (37 males and 31 females aged 35 ± 11) participated in a neuropsychological assessment of intellectual ability, verbal memory, and executive and psychomotor function. The clinical evaluation comprised administering (and video-recording) the unified myoclonus rating scale (UMRS) to assess the severity of each patient's myoclonus. Forty-six healthy volunteers (19 males and 27 females aged 32 ± 11) served as the control group for the neuropsychological tests. Results: The cognitive performance of the EPM1 patient group was impaired. Verbal Intelligence Quotient (VIQ) was below the average range (VIQ < 85) in 49% of the patients; further, Performance Intelligence Quotient (PIQ) was below average in 75% of the patients. The patients performed worse than the controls in both immediate and delayed story recall (p = 0.001); however, in the word list learning task, the patients performed only slightly worse than the controls. The one-hour delayed recall of the learned words was similar in both groups, and the percentage of retained words and story contents did not differ between the patients and controls. The patients were impaired in all of the executive function tests as well as in the psychomotor speed tests (p < 0.001 for all). Also, the patients' simple psychomotor speed in the tapping task was significantly slowed in comparison to controls (p < 0.001). Conclusion:The patients had impaired performance in the majority of the cognitive measures; they showed the highest level of impairment in all the executive function tests and in the psychomotor speed tests. The measures of these cognitive domains are timed-therefore, it is clear that severe myoclonus limits patients' performance. In contrast, verbal memory, especially delayed recall, was the least affected cognitive domain.

Cystatin B deficiency results in sustained histone H3 tail cleavage in postnatal mouse brain mediated by increased chromatin-associated cathepsin L activity

“…The key clinical features include treatment-resistant disabling myoclonus, tonic-clonic seizures and ataxia with widespread progressive brain degeneration in imaging studies. The overall cognitive functions of EPM1 patients are mostly within normal range ( Äikiä et al, 2021 ). In contrast, biallelic total loss-of-function CSTB mutations cause a neonatal-onset developmental encephalopathy with progressive microcephaly ( Mancini et al, 2016 ; O’Brien et al, 2017 ).…”

ILAE Genetics Literacy series: Progressive myoclonus epilepsies

“…The most commonly associated neurological manifestation is ataxia. Cognition is relatively preserved, although subtle impaired processing and executive function have been reported 18,19 . Psychiatric co‐morbidities are common, with high rates of depression and suicidal behaviour 18 .…”

Associations between cognition and employment outcomes after epilepsy surgery

“…mistakes) are summed together. As executive function deficits may be common in patients with epilepsy [24], executive function mistakes averaged across multiple tests may be a more ecologically valid measure of the underlying executive function deficit as performance may vary across different tests.…”